| Record ID | ia:distributionadmi0000nati |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/distributionadmi0000nati/distributionadmi0000nati_marc.xml |
| Download MARC binary | https://www.archive.org/download/distributionadmi0000nati/distributionadmi0000nati_meta.mrc |
LEADER: 01329cam a22002774a 4500
001 2003115709
003 DLC
005 20140422074438.0
008 031120s2004 dcua b 001 0 eng
010 $a 2003115709
020 $a0309090989 (book)
020 $a0309528119 (PDF)
040 $aDLC$cDLC$dDLC
042 $apcc
043 $an-us---
050 00 $aRC280.T6$bN386 2004
082 00 $a362.196/9897025/0973$222
110 2 $aNational Research Council (U.S.).$bCommittee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident.
245 10 $aDistribution and administration of potassium iodide in the event of a nuclear incident /$cCommittee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident, Board on Radiation Effects Research, Division of Earth and Life Studies, National Research Council of the National Academies.
260 $aWashington, DC :$bNational Academies Press,$cc2004.
300 $axiii, 248 p. :$bill. ;$c23 cm.
504 $aIncludes bibliographical references.
650 0 $aThyroid gland$xCancer$zUnited States$xPrevention.
650 0 $aPotassium iodide$xTherapeutic use.
650 0 $aRadioactive fallout$xHealth aspects.
710 2 $aNational Research Council (U.S.).$bBoard on Radiation Effects Research.